Of note, in prostate cancer, KLK-3, which is also commonly known as the prostate-specific antigen (PSA), has been used as a biomarker for prostate cancer screening, although its diagnostic value still remains controversial [68]. This evidence concerns the gene KLK3 and Familial prostate cancer.